Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation
- DOI
- 10.3390/ph15050568
- Published
- 2022-05-02
- Container
- Pharmaceuticals
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ph15050568,
title = {Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation},
author = {Aziz Unnisa and Ananda K. Chettupalli and Turki Al Hagbani and Mohammad Khalid and Suresh B. Jandrajupalli and Swarnalatha Chandolu and Talib Hussain},
year = {2022},
journal = {Pharmaceuticals},
doi = {10.3390/ph15050568},
url = {https://doi.org/10.3390/ph15050568}
}RIS
TY - JOUR TI - Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation AU - Aziz Unnisa AU - Ananda K. Chettupalli AU - Turki Al Hagbani AU - Mohammad Khalid AU - Suresh B. Jandrajupalli AU - Swarnalatha Chandolu AU - Talib Hussain PY - 2022 JO - Pharmaceuticals DO - 10.3390/ph15050568 UR - https://doi.org/10.3390/ph15050568 ER -
APA
Unnisa, A., Chettupalli, A. K., Hagbani, T. A., Khalid, M., Jandrajupalli, S. B., Chandolu, S., & Hussain, T. (2022). Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation. Pharmaceuticals. https://doi.org/10.3390/ph15050568
Source records
- crossref · retrieved 2026-09-25T05:13:56.097Z